Main content

Cancer patient: 'How can they put a price on my life?'

The NHS drugs watchdog in England has rejected a treatment that can extend the lives of some women with an advanced form of breast cancer because it's too expensive.

The high price of Kadcyla makes it "impossible" to recommend for widespread use in the health service, according to the National Institute for Health and Care Excellence.

Hayley Kalininis, 33, was diagnosed with breast cancer three years ago and been on Kadcyla for eighteen weeks.

This clip is originally from Breakfast 8th August 2014.

4 minutes

This clip is from

5 Live In Short

Featured in...

  • News5 Live In Short

    The best current affairs interviews, insight and analysis from 蜜芽传媒 Radio 5 live.

More clips from 5 Live In Short

See all clips from 5 Live In Short (14670)